Early Stage Partners, LP β Full Portfolio
12 tracked investments Β· listed companies and verified rows first
SeaStar Medical develops the Selective Cytopheretic Device (SCD), a therapy that targets highly activated neutrophils and monocytes to neutralize the hyperinflammatory immune response in critically ill ICU patients facing conditions such as infection, trauma, or surgery.
BiotechHealthtechMedical DevicesDenver, US
Eric Schlorff(Executive Officer, Director)inAlvin Vitangcol(Director)Kenneth Van Heel(Director)Leslie Bottorff(Director)William White(Director)H David Humes(Director)
Co-investorsAphelion CapitalCapital Midwest FundWMU Biosciences Research & Commercialization Center
ICN is a privately-owned corporation with an experienced management team, backed by venture capital investment.
AdTechCloud ComputingMarketing TechRetail TechSaaSSector AgnosticNew Canaan, US
Richard Thibedeau(Co-Founder & Chief Operating Officer)Jon Robertson(Co-Founder & EVP Marketing)Brian Schulte(Co-Founder & VP of IT)Gary Oakley(Executive Officer, Director)
BoardJames Petras(Director)Jonathan Murray(Director)
Co-investorsConnecticut InnovationsLaunchCapital
Cleveland, US
David Neundorfer(Executive Officer, Director)
BoardPeter Ziebelman(Director)Ralph Carter(Director)
Board seatJim PetrasΒ· per SEC Form D Β· $1M raise Β· filed Apr 2015
Arisdyne provides process technologies for industrial applications, working with process engineers and plant managers to improve outcomes in areas such as biodiesel production, wastewater and biogas treatment, and graphene manufacturing.
CleantechDeep TechNew Materials
Blue Spark Technologies develops wearable continuous vital sign monitoring technology used for patient monitoring in hospitals and out-of-hospital settings, and for data collection in clinical trials.
Digital HealthHealthtechMedical DevicesWestlake, US
ROBERT THOMPSON(Executive Officer)MATTHEW REAM(Executive Officer)JOHN GANNON(Executive Officer, Director)GARY TUCHOLSKI(Executive Officer)
BoardJAMES PETRAS(Director)inCECELIA CRUICKSHANK(Director)
HistoSonics develops a non-invasive medical device that uses histotripsy to mechanically destroy liver tumors, including unresectable ones, without surgery.
BiotechDeep TechHealthtechMedical DevicesAnn Arbor, GB
Wen Chen(Director)Tom Tefft(Director)Michael Blue(Executive Officer, Director)Fred Lee(Director)James Adox(Director)Thomas Davison(Executive Officer, Director)
Co-investorsAlpha Wave GlobalAmzak HealthHealthQuest CapitalLumira VenturesMichigan Capital NetworkBezos Expeditions+2 more
OnShift provides workforce management software purpose-built for senior care organizations, covering talent acquisition, scheduling, payroll and HRIS integrations, employee engagement and retention, and compliance reporting.
HealthtechHR TechSaaSCleveland, US
Mark Woodka(Executive Officer, Director)Michael Stubler(Director)Claiborne Rankin(Director)Jonathan Murray(Director)David Inglis(Director)
Co-investorsHLM Venture PartnersJumpstart Ventures
OPTEM (Ovation Polymer Technology & Engineered Materials) develops proprietary specialty and performance polymers and composites, including electrically and thermally conductive compounds and high-performance masterbatches, and offers toll and custom compounding services.
Advanced ManufacturingNew Materials
Company sold to a strategic investor in 2014.
Company sold to a strategic investor in 2014.
Software company sold to Oracle; largest-ever exit for an Ohio-based software company.
Co-investorsDraper Triangle
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.